Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes
文献类型：期刊论文
| 作者 | Zhang, Jiang-Wei; Liu, Yong; Li, Wei; Hao, Da-Cheng; Yang, Ling |
| 刊名 | european journal of clinical pharmacology
 |
| 出版日期 | 2006-07-01 |
| 卷号 | 62期号:7页码:497-502 |
| 关键词 | cytochrome P450 CYP2C9 drug-drug interaction medroxyprogesterone acetate (MPA) phenytoin |
| 产权排序 | 1;1 |
| 通讯作者 | 杨凌 |
| 英文摘要 | objective: medroxyprogesterone acetate (mpa), frequently used in contraception and chemotherapy, was involved in a report of drug-drug interaction (ddi) when co-administrated with phenytoin, doxifluridine and cyclophosphamide. in order to clarify the mechanism of such interaction, an in vitro study was undertaken to evaluate mpa's potential to inhibit cytochrome p450 (cyp) enzymes. methods: inhibitory effects of mpa on seven cyps, including cyp1a2, cyp2a6, cyp2c8, cyp2c9, cyp2d6, cyp2e1 and cyp3a4, were conducted in human liver microsomes. time- and nadph-dependent inhibitions were also tested. ddi potential was predicted according to the [i]/k-i value. results: mpa was found to inhibit cyp2c9 and cyp3a4; half inhibition concentration (ic50) was 16.1 mu m and 31.5 mu m, respectively. slight inhibition was observed on cyp1a2, cyp2a6, cyp2c8 and cyp2d6 with ic50 of more than 100 mu m. mpa exhibited activation rather than inhibition on cyp2e1. further study revealed that mpa showed a noncompetitive inhibition on cyp2c9 and a competitive inhibition on cyp3a4 with k (i) of 9.0 mu m and 36 mu m, respectively. in addition, mpa was not a mechanism-based inhibitor to any of seven isoforms tested. by using predicted concentration of mpa in liver, [i]/k (i) was estimated to be 0.24 and 0.06 for cyp2c9 and cyp3a4, respectively. the concentration of phenytoin co-administrated with mpa was calculated to increase by 24%. conclusions: based on our results, mpa can possibly cause clinically relevant ddi via the inhibition of cyp2c9. |
| WOS标题词 | science & technology ; life sciences & biomedicine |
| 类目[WOS] | pharmacology & pharmacy |
| 研究领域[WOS] | pharmacology & pharmacy |
| 关键词[WOS] | advanced breast-cancer ; drug-drug interactions ; in-vitro ; metabolic interaction ; endogenous steroids ; 5-fluorouracil ; microsomes ; 3a4 ; cyclophosphamide ; doxifluridine |
| 收录类别 | SCI |
| 原文出处 | true |
| 语种 | 英语 |
| WOS记录号 | WOS:000238832200001 |
| 公开日期 | 2010-11-30 |
| 源URL | [http://159.226.238.44/handle/321008/93865]  |
| 专题 | 大连化学物理研究所_中国科学院大连化学物理研究所 |
| 作者单位 | 1.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian 116023, Peoples R China 2.Chinese Acad Sci, Grad Sch, Beijing, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhang, Jiang-Wei,Liu, Yong,Li, Wei,et al. Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes[J]. european journal of clinical pharmacology,2006,62(7):497-502. |
| APA | Zhang, Jiang-Wei,Liu, Yong,Li, Wei,Hao, Da-Cheng,&Yang, Ling.(2006).Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes.european journal of clinical pharmacology,62(7),497-502. |
| MLA | Zhang, Jiang-Wei,et al."Inhibitory effect of medroxyprogesterone acetate on human liver cytochrome P450 enzymes".european journal of clinical pharmacology 62.7(2006):497-502. |
入库方式： OAI收割
来源：大连化学物理研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。